欧盟评估扩展使用转基因黑曲霉菌株MOX生产的过氧化物酶的安全?/h1>
放大字体缩小字体时间?024-04-12 14:20 来源:食品伙伴网 作者: 泽夕
核心提示?024??0日,欧盟食品安全局就一种食品酶过氧化物酶(peroxidase)的安全性评价发布意见、/div>
   食品伙伴网讯2024??0日, 欧盟食品安全局就一种食品酶过氧化物酶(peroxidase)的安全性评价发布意见
  据了解,这种食品酶是田a href='//www.sqrdapp.com/news/tag_2434.html' class='zdbq' title='转基因相关食品资? target='_blank'>转基囟/a> 黑曲霈/a>菌株MOX生产的,旨在用于加工乳制品以生产改良乳蛋白和生产植物基牛奶和奶制品类似物、/div>
  经过评估,专家小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。部分原文报道如下:
  The food enzyme peroxidase (phenolic donor: hydrogen-peroxide oxidoreductase, EC 1.11.1.7) is produced with the genetically modified Aspergillus niger strain MOX by DSM Food Specialties B.V. A safety e valuation of this food enzyme was made previously, in which EFSA co ncluded that this food enzyme did not give rise to safety co ncerns when used in one food manufacturing process. Subsequently, the applicant requested to extend its use to include an additio nal process. In this assessment, EFSA updated the safety e valuation of this food enzyme when used in a total of two food manufacturing processes: processing of dairy products for the production of modified milk proteins and the production of plant-ba sed analogues of milk and milk products. The dietary exposure to the food enzymeCtotal organic solids (TOS) was estimated to be up to 0.091 mg TOS/kg body weight (bw) per day in European populations. Using the no observed adverse effect level previously reported (2162 mg TOS/kg bw per day), the Panel derived a margin of exposure (MoE) of at least 23,758. ba sed on the data provided for the previous e valuation and the revised MoE, the Panel co ncluded that this food enzyme does not give rise to safety co ncerns under the revised intended co nditions of use.
   本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@www.sqrdapp.com、/span>
日期9a href="//www.sqrdapp.com/news/2024-04-12.html">2024-04-12
[ 食品资讯搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]

Baidu
map